It is expected that DREAMS will facilitate ground-breaking improvements in the development of therapies for RDs, specifically by developing innovative methodologies and tools that will depict the commonalities shared by the group of selected NMDs diseases. The generated knowledge is going to change the actual paradigm for developing therapies for RDs.
To achieve its purpose, DREAMS intends, on the one hand, to describe the common pathophysiological aspects of rare NMDs and, on the other hand, to generate a reusable drug discovery platform to accelerate and make economically viable the discovery of common drug therapies.
DREAMS' MAIN
DREAMS'
01
The creation of cellular assays of our starting diseases and the generation of data through these assays.
02
The discovery and validation of drugs and extended therapeutic indications.
03
The preparation of clinical validation of our treatments.
